<DOC>
	<DOCNO>NCT00517322</DOCNO>
	<brief_summary>Aim study compare hypertensive patient effect one year therapy ACE-inhibitor ( RAMIPRIL ) angiotensin II receptor blocker ( IRBESARTAN ) leave atrial remodelling diastolic function .</brief_summary>
	<brief_title>Left Atrial Remodelling Hypertension : Effects Ramipril Irbesartan</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Atrial Remodeling</mesh_term>
	<mesh_term>Ramipril</mesh_term>
	<mesh_term>Irbesartan</mesh_term>
	<criteria>Â· mild moderate essential hypertension antihypertensive treatment good quality echocardiogram cardiovascular disease ( AMI , stroke TIA ) heart failure , valvular heart disease diabetes secondary hypertension atrial fibrillation hepatic renal severe failure pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>leave atrial volume</keyword>
	<keyword>hypertension</keyword>
	<keyword>ramipril</keyword>
	<keyword>irbesartan</keyword>
	<keyword>diastolic function</keyword>
</DOC>